Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Vaxart, Inc. market cap for the quarter ending 2026-07-31 was $131.13M, a 43.21% increase year-over-year.
Vaxart, Inc. market cap for the quarter ending 2026-06-30 was $148.13M, a 43.07% increase year-over-year.
Vaxart, Inc. market cap for the quarter ending 2026-05-01 was $186.32M, a 114.84% increase year-over-year.
Vaxart, Inc. market cap for the quarter ending 2026-03-31 was $147.26M, a 57.38% increase year-over-year.
Vaxart, Inc. market cap for fiscal 2026 was $131.13M.
Vaxart, Inc. market cap for fiscal 2025 was $84.17M, a 44.01% decline from fiscal 2024.
Vaxart, Inc. market cap for fiscal 2024 was $150.33M, a 71.87% increase from fiscal 2023.
Vaxart, Inc. market cap for fiscal 2023 was $87.47M, a 32.11% decline from fiscal 2022.